Physician profile
Steven A Wool
NPI 1780789800
$18,899.57
in general payments reported to CMS, 2019-2025
74 companies · $2,551 in 2025
The $2,551 reported for 2025 was more than what 95% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,301 · 2020: $2,192 · 2021: $2,050 · 2022: $2,718 · 2023: $2,723 · 2024: $3,364 · 2025: $2,551.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,519 · Education: $119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,519.34 |
| Education | $118.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,686.48 | 2019-2025 | Vraylar, Qulipta, Ubrelvy |
| Amgen INC. | $1,471.39 | 2019-2025 | Repatha, Evenity, Otezla |
| Astrazeneca Pharmaceuticals LP | $1,351.76 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Glaxosmithkline, LLC. | $1,236.53 | 2019-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $999.12 | 2019-2025 | Jardiance |
| Lilly USA, LLC | $924.46 | 2019-2025 | Mounjaro, Kisunla, Emgality |
| Abbott Laboratories | $803.21 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2, Eterna |
| Baxter Healthcare | $722.64 | 2022-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Novartis Pharmaceuticals Corporation | $647.75 | 2019-2025 | |
| Pfizer INC. | $644.04 | 2019-2025 | |
| Radius Health, INC. | $532.46 | 2019-2024 | Tymlos |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $510.85 | 2019-2025 | Xifaxan, Trulance, Relistor |
| Viiv Healthcare Company | $410.87 | 2022-2024 | Apretude |
| Novo Nordisk INC | $398.39 | 2019-2025 | Ozempic, Rybelsus |
| Amarin Pharma, INC. | $387.58 | 2019-2020 |
Show all 74 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Wool listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.